General form of registration statement for all companies including face-amount certificate companies

Equity Based Awards (Tables)

v3.21.2
Equity Based Awards (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]    
Summary of Option activity under the plan for the year Option activity under the plan for the year to date period ending June 30, 2021 is as follows:
 
 
  
Number of
Shares
 
  
Weighted-
Average
Exercise
Price
(Per
Share)
 
  
Weighted-
Average
Remaining
Contractual
Life
(in years)
 
Outstanding at December 31, 2020
     19,420,305     $ 1.72        8.71  
Exercised
     (857,343     0.49           
Forfeited
     (163,894     1.91           
    
 
 
                  
Outstanding at June 30, 2021
     18,399,068     $ 1.78        8.33  
    
 
 
                  
Options exercisable at June 30, 2021
     5,648,643     $ 1.31        7.07  
Option activity under the plan for the year ended December 31, 2020 is as follows:
 
    
Number of
Shares
    
Weighted-Average

Exercise Price
(Per Share)
    
Weighted-Average

Remaining
Contractual Life
(in years)
 
Outstanding at December 31, 2019
     13,162,473      $ 1.16        7.51  
Granted
     9,890,563        2.06           
Exercised
     (2,231,540      0.42           
Forfeited
     (1,401,191      1.08           
    
 
 
                   
Outstanding at December
 31,
2020
     19,420,305      $ 1.72        8.71  
    
 
 
                   
Options exercisable at December
 31, 2019
     4,561,561        0.37        4.14  
Options exercisable at December
 31, 2020
     4,700,993      $ 0.98        6.84  
Summary of Additional information regarding the exercise of stock options
Additional information regarding the exercise of stock options is as follows:
 
 
  
Six Months Ended
June 30,
 
(in thousands, except weighted average)
  
2021
 
  
2020
 
Weighted-average grant date fair value of options
granted
  
$
—  
 
  
$
1.01
 
Intrinsic value of options exercised
  
 
6,450
 
  
 
2,017
 
Additional information regarding the exercise of stock options is as follows:
 
(in thousands, except weighted average)
  
2020
    
2019
 
Weighted-average grant date fair value of options granted
   $ 1.28      $ 0.92  
Intrinsic value of options exercised
     4,455        3,909  
Summary of calculated via the Black-Scholes option pricing model
 
  
Six Months
Ended
June 30, 2020
 
Expected option term (in years)
  
 
6.06
 
Expected volatility%
  
 
52.2
Risk-free interest rate%
  
 
1.50
Expected dividend yield%
  
 
0
Fair value of common stock (per share)
  
$
1.01
 
 
    
Year Ended
December 31,
 
    
2020
   
2019
 
Expected option term (in years)
     5.86       6.07  
Expected volatility
     53.1     52.6
Risk-free interest rate
     0.56     1.89
Expected dividend yield
     —       —  
Fair value of common stock (per share)
   $ 2.36     $ 1.81  
Summary of consolidated statements of operations and comprehensive loss
During the three and six months ended June 30, 2021 and 2020, the Company recognized the following stock-based compensation expense in the following captions within the condensed consolidated statements of operations and comprehensive loss:
 
 
  
Three Months
Ended June 30,
 
  
Six Months Ended
June 30,
 
(in thousands)
  
2021
 
  
2020
 
  
2021
 
  
2020
 
Cost of revenue
  
$
62
 
  
$
124
 
  
$
89
 
  
$
258
 
Research and development
  
 
394
 
  
 
171
 
  
 
725
 
  
 
225
 
Sales and marketing
  
 
237
 
  
 
135
 
  
 
320
 
  
 
227
 
General and administrative
  
 
1,084
 
  
 
73
 
  
 
1,837
 
  
 
297
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Total stock-based compensation expense
  
$
1,777
 
  
$
503
 
  
$
2,971
 
  
$
1,007
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
The Company recorded compensation expense for the stock options of $2.6 million and $0.9 million for the years ended December 31, 2020 and 2019, respectively, which was recognized in the following captions within the consolidated statements of operations and comprehensive loss:
 
    
Year Ended
December 31,
 
(in thousands)
  
2020
    
2019
 
Cost of revenue
   $ 589      $ 186  
Research and development
     693        307  
Sales and marketing
     578        262  
General and administrative
     709        103  
    
 
 
    
 
 
 
Total stock-based compensation expense
   $ 2,569      $ 858  
    
 
 
    
 
 
 
Summary of restricted stock units activity The following table summarizes the restricted stock unit activity for the
year-to-date
period ending June 30, 2021:
 
  
Number of
Shares
 
  
Weighted-
Average
Grant Date Fair Value
(Per
Share)
 
Outstanding at December 31, 2020
  
 
—  
 
  
$
—  
 
Granted
  
 
1,494,250
 
  
 
8.17
 
Vested
  
 
—  
 
  
 
—  
 
Forfeited
  
 
(4,000
  
 
8.01
 
  
 
 
 
  
Unvested at June 30, 2021
  
 
1,490,250
 
  
$
8.17
 
  
 
 
 
  
 
Summary of stock based compensation based on the awards granted
 
  
Three Months
Ended June 30,
 
  
Six Months Ended
June 30,
 
(in thousands)
  
2021
 
  
2020
 
  
2021
 
  
2020
 
Stock Options
  
$
1,188
 
  
$
503
 
  
$
2,382
 
  
$
1,007
 
Restricted Stock Units
  
 
589
 
  
 
—  
 
  
 
589
 
  
 
—  
 
  
 
 
 
  
 
 
 
  
 
 
 
  
 
 
 
Total stock-based compensation expense
  
$
1,777
 
  
$
503
 
  
$
2,971
 
  
$
1,007